NewsBenzingaUBS Maintains Buy on Expeditors International, Raises Price Target to $220 UBS Maintains Buy on Expeditors International, Raises Price Target to $220 Benzinga 2026.10.02 19:03 (GMT+0) Open on Benzinga Other news If You Invested $100 In Flowserve Stock 5 Years Ago, You Would Have This Much Today $1000 Invested In Cogent Biosciences 5 Years Ago Would Be Worth This Much Today ICBA Sues OCC Over Crypto Trust Charters Tonix Pharmaceuticals Says Dr. Reddy's Files ANDA With Paragraph IV Patent Certification For Generic TONMYA On Oct 1; Paragraph IV Certification Challenges Four TONMYA Patents Listed In FDA Orange Book; Co Intends To Enforce TONMYA Intellectual Property... NeoVolta Files Prospectus Related To The Resale Of Up To 1.5M Shares Of Common Stock Selling Stockholders If You Invested $100 In Republic Services Stock 10 Years Ago, You Would Have This Much Today
Tonix Pharmaceuticals Says Dr. Reddy's Files ANDA With Paragraph IV Patent Certification For Generic TONMYA On Oct 1; Paragraph IV Certification Challenges Four TONMYA Patents Listed In FDA Orange Book; Co Intends To Enforce TONMYA Intellectual Property...
NeoVolta Files Prospectus Related To The Resale Of Up To 1.5M Shares Of Common Stock Selling Stockholders
